SHCBP1 and neoplasm: Our previous data showed that SHCBP1 knockdown led to early M-phase entry by downregulating WEE1 expression and subsequently reducing CDK1 phosphorylation at Tyr15, resulting in the abrogation of the G2–M checkpoint in tumour cells (Fig. 4).